Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Microfluidics Market to Reach $37.2 Billion by 2030, Driven by Point-of-Care Diagnostics and Personalized Medicine

globenewswire.com
ABT Abbott Laboratories is mentioned as a prominent company in the microfluidics market, which is projected to grow significantly. The article does not provide specific sentiment towards Abbott's performance within this market. A Agilent Technologies is listed as a prominent company in the microfluidics market, which is expected to experience substantial growth. The article does not offer specific sentiment regarding Agilent's position or performance. BIO Bio-Rad Laboratories is identified as a prominent player in the microfluidics market, a sector poised for significant expansion. The article does not convey specific sentiment about Bio-Rad's prospects within this market. DHR Danaher Corporation is highlighted as a prominent company and a focus of competitive assessment within the growing microfluidics market. The article does not provide specific sentiment on Danaher's performance. IDXX IDEX Corporation is mentioned as a prominent company in the microfluidics market, which is projected to grow significantly. The article does not provide specific sentiment towards IDEX's performance within this market. ILMN Illumina, Inc. is noted as a prominent company and a focus of competitive assessment in the expanding microfluidics market. The article does not express specific sentiment regarding Illumina's performance. QDEL QuidelOrtho Corporation is mentioned as a prominent company in the microfluidics market, which is projected to grow significantly. The article does not provide specific sentiment towards QuidelOrtho's performance within this market. HOLX Hologic, Inc. is listed as a prominent company in the microfluidics market, which is expected to grow substantially. The article does not offer specific sentiment about Hologic's position or performance. TMO Thermo Fisher Scientific is identified as a prominent company and a focus of competitive assessment in the growing microfluidics market. The article does not provide specific sentiment on Thermo Fisher's performance. FTV Fortive Corporation is mentioned as a prominent company in the microfluidics market, which is projected to grow significantly. The article does not provide specific sentiment towards Fortive's performance within this market. PH Parker Hannifin Corporation is listed as a prominent company in the microfluidics market, which is expected to grow substantially. The article does not offer specific sentiment about Parker Hannifin's position or performance.

Microfluidics Market to Reach $37.2 Billion by 2030, Driven by Point-of-Care Diagnostics and Personalized Medicine Dublin, July 23, 2026 (GLOBE NEWSWIRE) -- The "Microfluidics Market by Product, Material, Application, End User - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering.

The global microfluidics market is projected to grow from USD 24.96 billion in 2025 to USD 37.2 billion by 2030, registering a compound annual growth rate (CAGR) of 8.3% during the forecast period. Market expansion is being supported by rising demand for point-of-care diagnostics, advances in drug delivery and organ-on-a-chip technologies, increased adoption of personalized medicine, and continued growth in genomics and proteomics research.

The increasing prevalence of chronic diseases, including cancer and diabetes, is strengthening demand for rapid and accurate diagnostic solutions. Microfluidic technologies are also gaining importance in infectious disease testing, clinical research, pharmaceutical development and life sciences applications. However, high device costs and stringent regulatory requirements remain key market restraints. The expanding number of diagnostic centers presents an important growth opportunity.

Polymers Held the Largest Market Share

Polymers accounted for the largest share of the microfluidics market due to their cost efficiency, manufacturing flexibility and suitability for medical applications. Polydimethylsiloxane (PDMS), polymethyl methacrylate (PMMA) and cyclic olefin copolymer (COC) are widely used to manufacture microfluidic channels and structures.

Compared with conventional materials such as silicon and glass, polymers offer easier molding and lower production costs. Their biocompatibility supports adoption across medication delivery, lab-on-a-chip systems and diagnostic applications. These advantages are expected to sustain the polymers segment’s leading market position.

Hospitals and Diagnostic Centers to Record the Highest Growth Rate

Hospitals and diagnostic centers are expected to register the highest growth rate during the forecast period. Demand is being driven by the need for rapid, on-site testing that can improve clinical decision-making and patient outcomes. Microfluidic systems support faster testing, greater precision and more accurate diagnostic results while helping healthcare providers streamline workflows and control costs.

The rise in infectious diseases, including COVID-19, has reinforced the need for efficient diagnostic technologies in clinical environments. Continued investment in point-of-care testing and the growing number of diagnostic centers are anticipated to accelerate adoption throughout this end-user segment.

Asia-Pacific Positioned as the Fastest-Growing Regional Market

Asia-Pacific is projected to record the highest CAGR, including during the referenced 2024-2029 period. The regional analysis covers China, India, Japan, Australia, South Korea and the Rest of Asia Pacific. Growth is supported by increasing demand for advanced technologies, particularly in China, India and Japan, alongside government initiatives to expand academic and scientific research.

Japan allocated USD 64.26 billion to its Sixth Science, Technology and Innovation Basic Plan for 2021-2025. Across Asia Pacific, the rising incidence of chronic and infectious diseases, together with increased interest in early diagnosis and preventive care, is expanding the use of microfluidic devices. Rapid growth in the region’s pharmaceutical and life sciences sectors is also stimulating research and development activity and increasing demand for microfluidics.

Competitive Landscape

Prominent companies operating in the microfluidics market include Abbott Laboratories, Agilent Technologies, Aignep S.p.A., bioMérieux, BD, Bio-Rad Laboratories, Danaher Corporation, Illumina, Parker Hannifin Corporation, Thermo Fisher Scientific, SMC Corporation, IDEX Corporation, Fortive Corporation, PerkinElmer, F. Hoffmann-La Roche, Standard BioTools, QuidelOrtho Corporation, Hologic, Dolomite Microfluidics and Elveflow.

The competitive assessment examines market share, products, services and key strategies, with particular focus on Danaher Corporation, Illumina, bioMérieux, Thermo Fisher Scientific and Abbott Laboratories. It also reviews technology development, research and development initiatives, product and service launches, geographic expansion, recent industry developments and investment activity.

Research Coverage

The market report segments the microfluidics industry by product, application, end user and geographic region. It evaluates the principal drivers, restraints, opportunities and challenges influencing market growth, while assessing competitive conditions, revenue potential and the performance of individual micromarkets. Segment revenue forecasts cover five major regions.

Key Attributes

Market Dynamics

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/me5ttg

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment